Optimization of 4-arylthiophene-3-carboxylic acid derivatives as inhibitors of ANO1: Lead optimization studies toward their analgesic efficacy for inflammatory pain-Reference-Cited by-同舟云学术

Optimization of 4-arylthiophene-3-carboxylic acid derivatives as inhibitors of ANO1: Lead optimization studies toward their analgesic efficacy for inflammatory pain

Published:2022-07 Issue: Volume:237 Page:114413
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wang Yuxi,Hu Xiaoyue,Huang Han,Jin Zefang,Gao Jian,Guo Yi,Zhong Yi,Li Zhongtang,Zong Xiaolin,Wang Kewei^ORCID,Zhang Liangren,Liu Zhenming^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference52 articles.

1. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity;Caputo;Science,2008

2. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit;Schroeder;Cell,2008

3. TMEM16A confers receptor-activated calcium-dependent chloride conductance;Yang;Nature,2008

4. TMEM16A/anoctamin 1 protein mediates calcium-activated chloride currents in pulmonary arterial smooth muscle cells;Manoury;J. Physiol.,2010

5. Loss of TMEM16A causes a defect in epithelial Ca2+-dependent chloride transport;Ousingsawat;J. Biol. Chem.,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anoctamin 1, a multi-modal player in pain and itch;Cell Calcium;2024-11

2. Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis;2024-05-08

3. Selective Catalytic Hydrodebromination of 2,3,4,5-Tetrabromothiophene with Hydrogen on a Palladium Catalyst;Catalysis in Industry;2023-12

4. An Overview of the Mechanisms Involved in Neuralgia;Journal of Inflammation Research;2023-09

5. ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers;Frontiers in Pharmacology;2023-05-18